122 related articles for article (PubMed ID: 38484637)
21. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
23. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
24. A well-matched marriage of immunotherapy and radiofrequency ablation to reduce the relapse and progression of hepatocellular carcinoma.
Liao R; Song P; Duan Y; Ye W; Yin K; Kang M; Yu Y; Yang J; Tang W
Biosci Trends; 2022 Nov; 16(5):377-380. PubMed ID: 36089338
[TBL] [Abstract][Full Text] [Related]
25. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
26. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
[TBL] [Abstract][Full Text] [Related]
27. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
28. Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology.
Goossens C; Nahon P; Le Moyec L; Triba MN; Bouchemal N; Amathieu R; Ganne-Carrié N; Ziol M; Trinchet JC; Sellier N; Diallo A; Seror O; Savarin P
J Proteome Res; 2016 May; 15(5):1446-54. PubMed ID: 27015127
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression.
Cao S; Zou Y; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J
Int J Hyperthermia; 2022; 39(1):1-7. PubMed ID: 34937501
[TBL] [Abstract][Full Text] [Related]
30. Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Analysis.
Takata K; Tanaka T; Anan A; Fukunaga A; Nagata T; Fukuda H; Yamauchi R; Kunimoto H; Yokoyama K; Morihara D; Takeyama Y; Iwata K; Shakado S; Sakisaka S; Hirai F
Oncology; 2022; 100(6):303-312. PubMed ID: 35114665
[TBL] [Abstract][Full Text] [Related]
31. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
[TBL] [Abstract][Full Text] [Related]
32. Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
Lin CC; Lui KW; Chen WT; Hsieh YC; Cheng YT; Teng W; Lin SM
Eur Radiol; 2021 Nov; 31(11):8649-8661. PubMed ID: 33895858
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
34. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation in the treatment of hepatocellular carcinoma.
Deng Q; He M; Fu C; Feng K; Ma K; Zhang L
Int J Hyperthermia; 2022; 39(1):1052-1063. PubMed ID: 35944905
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes after radiofrequency ablation in patients with non-B non-C hepatocellular carcinoma within Milan criteria: comparison with HBV-related hepatocellular carcinoma.
Liu B; Tan Y; Shen H; Wang L; Huang G; Huang T; Long H; Xie X; Xie X
Int J Hyperthermia; 2023; 40(1):2244207. PubMed ID: 37580046
[TBL] [Abstract][Full Text] [Related]
37. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
[TBL] [Abstract][Full Text] [Related]
38. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
39. Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.
Qi X; Li G; Liu D; Motamarry A; Huang X; Wolfe AM; Helke KL; Haemmerich D; Staveley-O'Carroll KF; Kimchi ET
Cancer Biol Ther; 2015; 16(12):1812-9. PubMed ID: 26537481
[TBL] [Abstract][Full Text] [Related]
40. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]